Indian authorities have seized more than 260 suspected counterfeit injection pens of Eli Lilly's Mounjaro — a drug approved in India for diabetes and weight loss that became the country's top-selling pharmaceutical by value after its 2025 launch. Officials from Haryana state recovered the fake pens from a vehicle on the outskirts of New Delhi and arrested two people accused of manufacturing and distributing them. Investigators say the main suspect sourced raw materials from vendors on the Chinese e-commerce platform Alibaba, raising concerns about the cross-border supply chains enabling drug counterfeiting in one of the world's largest medicines markets.